Skip to main content
Top
Published in: International Journal of Hematology 4/2009

01-05-2009 | Original Article

Adult precursor B lymphoblastic leukemia in Shanghai, China: characterization of phenotype, cytogenetics and outcome for 137 consecutive cases

Authors: Liming Bao, Sherilyn A. Gross, John Ryder, Xiaoqin Wang, Meirong Ji, Yan Chen, Yongchen Yang, Saijuan Zhu, Richard D. Irons

Published in: International Journal of Hematology | Issue 4/2009

Login to get access

Abstract

Acute lymphoblastic leukemia (ALL) accounts for 20–30% of adult leukemia in the West. However, detailed studies of B-cell-specific ALL in adult Asian populations are lacking. We diagnosed and characterized 137 consecutive cases of precursor B lymphoblastic leukemia (precursor B-cell ALL) presented to our laboratory in Shanghai using the WHO 2001 classification system. Patient clinical, phenotypic and cytogenetic characteristics were correlated with outcome. In contrast to Western studies, females (71) outnumbered males (66) partly due to an increased prevalence of the CD10− pro B-cell phenotype. Females with a CD10− pro B-cell phenotype exhibited significantly better overall survival than males. The most common cytogenetic abnormality was the Philadelphia chromosome (PH/BCR/ABL) which was found in approximately 37% of the cases. Cases of precursor B cell ALL lacking the PH/BCR/ABL genotype exhibited a pronounced age-dependent, gender prevalence with a modal age in the sixth decade for females compared to the second decade for males. These findings suggest significant geographic heterogeneity in precursor B-cell ALL which may be of both etiological and therapeutic significance.
Literature
1.
go back to reference Cortes JE, Kantarjian HM. Acute lymphoblastic leukemia. A comprehensive review with emphasis on biology and therapy. Cancer. 1995;76:2393–417.CrossRefPubMed Cortes JE, Kantarjian HM. Acute lymphoblastic leukemia. A comprehensive review with emphasis on biology and therapy. Cancer. 1995;76:2393–417.CrossRefPubMed
2.
go back to reference Velizarova M, Popova D, Hadjiev E, et al. Molecular-cytogenetic aberrations in B-cell adult acute lymphoblastic leukemia (B-ALL)—frequency and correlation with immunophenotype. Turk J Hematol. 2006;23:151–7. Velizarova M, Popova D, Hadjiev E, et al. Molecular-cytogenetic aberrations in B-cell adult acute lymphoblastic leukemia (B-ALL)—frequency and correlation with immunophenotype. Turk J Hematol. 2006;23:151–7.
3.
go back to reference Jaffe E, Harris N, Stein H, Vardiman J. World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2001. Jaffe E, Harris N, Stein H, Vardiman J. World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2001.
4.
go back to reference Wang J, Young L, Win W, Taylor CR. Distribution and Zap-70 Expression of WHO Lymphoma Categories in Shanxi, China: a Review of 447 Cases Using a Tissue Microarray Technique. Appl Immunohistochem Mol Morphol. 2005;13:323–32.CrossRefPubMed Wang J, Young L, Win W, Taylor CR. Distribution and Zap-70 Expression of WHO Lymphoma Categories in Shanxi, China: a Review of 447 Cases Using a Tissue Microarray Technique. Appl Immunohistochem Mol Morphol. 2005;13:323–32.CrossRefPubMed
5.
go back to reference Gross S, Zhu X, Bao L, et al. A prospective study of 728 cases of non-Hodgkin lymphoma from a single laboratory in Shanghai, China. Int J Hematol. 2008;88(2):165–73.CrossRefPubMed Gross S, Zhu X, Bao L, et al. A prospective study of 728 cases of non-Hodgkin lymphoma from a single laboratory in Shanghai, China. Int J Hematol. 2008;88(2):165–73.CrossRefPubMed
6.
go back to reference Gokbuget N, Hoelzer D. Recent approaches in acute lymphoblastic leukemia in adults. Rev Clin Exp Hematol. 2002;6:114–41.CrossRefPubMed Gokbuget N, Hoelzer D. Recent approaches in acute lymphoblastic leukemia in adults. Rev Clin Exp Hematol. 2002;6:114–41.CrossRefPubMed
7.
go back to reference Lenormand B, Bene MC, Lesesve JF, et al. PreB1 (CD10−) acute lymphoblastic leukemia: immunophenotypic and genomic characteristics, clinical features and outcome in 38 adults and 26 children. The Groupe D’etude Immunologique Des Leucemies. Leuk Lymphoma. 1998;28:329–42.CrossRefPubMed Lenormand B, Bene MC, Lesesve JF, et al. PreB1 (CD10−) acute lymphoblastic leukemia: immunophenotypic and genomic characteristics, clinical features and outcome in 38 adults and 26 children. The Groupe D’etude Immunologique Des Leucemies. Leuk Lymphoma. 1998;28:329–42.CrossRefPubMed
8.
go back to reference Armstrong SA, Look AT. Molecular genetics of acute lymphoblastic leukemia. J Clin Oncol. 2005;23:6306–15.CrossRefPubMed Armstrong SA, Look AT. Molecular genetics of acute lymphoblastic leukemia. J Clin Oncol. 2005;23:6306–15.CrossRefPubMed
9.
go back to reference Bloomfield CD, Secker-Walker LM, Goldman AI, et al. Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia. Cancer Genet Cytogenet. 1989;40:171–85.CrossRefPubMed Bloomfield CD, Secker-Walker LM, Goldman AI, et al. Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia. Cancer Genet Cytogenet. 1989;40:171–85.CrossRefPubMed
10.
go back to reference Dombret H, Gabert J, Boiron JM, et al. Outcome of treatment in adults with philadelphia chromosome-positive acute lymphoblastic leukemia—results of the prospective multicenter Lala-94 trial. Blood. 2002;100:2357–66.CrossRefPubMed Dombret H, Gabert J, Boiron JM, et al. Outcome of treatment in adults with philadelphia chromosome-positive acute lymphoblastic leukemia—results of the prospective multicenter Lala-94 trial. Blood. 2002;100:2357–66.CrossRefPubMed
11.
go back to reference Faderl S, Kantarjian HM, Thomas DA, et al. Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia. Leuk Lymphoma. 2000;36:263–73.CrossRefPubMed Faderl S, Kantarjian HM, Thomas DA, et al. Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia. Leuk Lymphoma. 2000;36:263–73.CrossRefPubMed
12.
go back to reference Ko BS, Tang JL, Lee FY, et al. Additional chromosomal abnormalities and variability of BCR breakpoints in philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan. Am J Hematol. 2002;71:291–9.CrossRefPubMed Ko BS, Tang JL, Lee FY, et al. Additional chromosomal abnormalities and variability of BCR breakpoints in philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan. Am J Hematol. 2002;71:291–9.CrossRefPubMed
13.
go back to reference Larson RA, Dodge RK, Burns CP, et al. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group b study 8811. Blood. 1995;85:2025–37.PubMed Larson RA, Dodge RK, Burns CP, et al. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group b study 8811. Blood. 1995;85:2025–37.PubMed
14.
go back to reference Secker-Walker LM, Craig JM. Prognostic implications of breakpoint and linage heterogeneity in Philadelphia-positive acute lymphoblastic leukemia: a review. Leukemia. 1993;7:147–51.PubMed Secker-Walker LM, Craig JM. Prognostic implications of breakpoint and linage heterogeneity in Philadelphia-positive acute lymphoblastic leukemia: a review. Leukemia. 1993;7:147–51.PubMed
15.
go back to reference Wetzler M, Dodge RK, Mrozek K, et al. Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a study of the cancer and leukaemia group B. Br J Haematol. 2004;124:275–88.CrossRefPubMed Wetzler M, Dodge RK, Mrozek K, et al. Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a study of the cancer and leukaemia group B. Br J Haematol. 2004;124:275–88.CrossRefPubMed
16.
go back to reference Gleissner B, Rieder H, Thiel E, et al. Prospective BCR-ABL analysis by polymerase chain reaction (RR-PCR) in adult acute B-lineage lymphoblastic leukemia: reliability of RT-nested-PCR and comparison to cytogenetic data. Leukemia. 2001;15:1834–40.CrossRefPubMed Gleissner B, Rieder H, Thiel E, et al. Prospective BCR-ABL analysis by polymerase chain reaction (RR-PCR) in adult acute B-lineage lymphoblastic leukemia: reliability of RT-nested-PCR and comparison to cytogenetic data. Leukemia. 2001;15:1834–40.CrossRefPubMed
17.
go back to reference de Labarthe A, Rousselot P, Huguet-Rigal F, et al. Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the Graaph-2003 study. Blood. 2007;109:1408–13.CrossRefPubMed de Labarthe A, Rousselot P, Huguet-Rigal F, et al. Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the Graaph-2003 study. Blood. 2007;109:1408–13.CrossRefPubMed
18.
go back to reference Lee S, Kim YJ, Min CK, et al. The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood. 2005;105:3449–57.CrossRefPubMed Lee S, Kim YJ, Min CK, et al. The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood. 2005;105:3449–57.CrossRefPubMed
19.
go back to reference Piccaluga PP, Martinelli G, Rondoni M, Visani G, Baccarani M. Advances and potential treatment for Philadelphia chromosome-positive adult acute lymphoid leukaemia. Expert Opin Biol Ther. 2006;6:1011–22.CrossRefPubMed Piccaluga PP, Martinelli G, Rondoni M, Visani G, Baccarani M. Advances and potential treatment for Philadelphia chromosome-positive adult acute lymphoid leukaemia. Expert Opin Biol Ther. 2006;6:1011–22.CrossRefPubMed
20.
go back to reference Johansson B, Mertens F, Mitelman F. Geographic heterogeneity of neoplasia-associated chromosome aberrations. Genes Chromosom Cancer. 1991;3:1–7.CrossRefPubMed Johansson B, Mertens F, Mitelman F. Geographic heterogeneity of neoplasia-associated chromosome aberrations. Genes Chromosom Cancer. 1991;3:1–7.CrossRefPubMed
21.
go back to reference Copelan EA, McGuire EA. The biology and treatment of acute lymphoblastic leukemia in adults. Blood. 1995;85:1151–68.PubMed Copelan EA, McGuire EA. The biology and treatment of acute lymphoblastic leukemia in adults. Blood. 1995;85:1151–68.PubMed
22.
go back to reference Bao L, Wang X, Ryder J, et al. Prospective study of 174 de novo acute myelogenous leukemias according to the WHO classification: subtypes, cytogenetic features and Flt3 mutations. Eur J Haematol. 2006;77:35–45.CrossRefPubMed Bao L, Wang X, Ryder J, et al. Prospective study of 174 de novo acute myelogenous leukemias according to the WHO classification: subtypes, cytogenetic features and Flt3 mutations. Eur J Haematol. 2006;77:35–45.CrossRefPubMed
23.
go back to reference Kantarjian HM, Talpaz M, Dhingra K, et al. Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia. Blood. 1991;78:2411–8.PubMed Kantarjian HM, Talpaz M, Dhingra K, et al. Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia. Blood. 1991;78:2411–8.PubMed
24.
go back to reference Shaffer LG, Tommerup N. An international system for human cytogenetic nomenclature (2005): recommendations of the International Standing Committee on Human Cytogenetic Nomenclature. Farmington, CT: Basel; Karger; 2005. Shaffer LG, Tommerup N. An international system for human cytogenetic nomenclature (2005): recommendations of the International Standing Committee on Human Cytogenetic Nomenclature. Farmington, CT: Basel; Karger; 2005.
25.
go back to reference Cross NC, Melo JV, Feng L, Goldman JM. An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion MRNAs in haematological disorders. Leukemia. 1994;8:186–9.PubMed Cross NC, Melo JV, Feng L, Goldman JM. An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion MRNAs in haematological disorders. Leukemia. 1994;8:186–9.PubMed
26.
go back to reference Simon R, Lee YJ. Nonparametric confidence limits for survival probabilities and median survival time. Cancer Treat Reps. 1982;66:37–42. Simon R, Lee YJ. Nonparametric confidence limits for survival probabilities and median survival time. Cancer Treat Reps. 1982;66:37–42.
27.
go back to reference Ko BS, Tang JL, Tsai W, et al. Philadelphia chromosome-positive acute lymphoblastic leukemia in Taiwan. Ann Hematol. 2001;80:510–5.CrossRefPubMed Ko BS, Tang JL, Tsai W, et al. Philadelphia chromosome-positive acute lymphoblastic leukemia in Taiwan. Ann Hematol. 2001;80:510–5.CrossRefPubMed
28.
go back to reference Qiu JY, Zhu W, Zhang Y, et al. Cytogenetic and clinical study of Philadelphia chromosome positive adult acute leukemia. Chinese. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005;13:358–63.PubMed Qiu JY, Zhu W, Zhang Y, et al. Cytogenetic and clinical study of Philadelphia chromosome positive adult acute leukemia. Chinese. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005;13:358–63.PubMed
29.
go back to reference Houot R, Tavernier E, Le QH, Lheritier V, Thiebaut A, Thomas X. Philadelphia chromosome-positive acute lymphoblastic leukemia in the elderly: prognostic factors and treatment outcome. Hematology. 2004;9:369–76.CrossRefPubMed Houot R, Tavernier E, Le QH, Lheritier V, Thiebaut A, Thomas X. Philadelphia chromosome-positive acute lymphoblastic leukemia in the elderly: prognostic factors and treatment outcome. Hematology. 2004;9:369–76.CrossRefPubMed
30.
go back to reference Gleissner B, Gokbuget N, Bartram CR, et al. Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German multicenter trial group and confirmed polymerase chain reaction analysis. Blood. 2002;99:1536–43.CrossRefPubMed Gleissner B, Gokbuget N, Bartram CR, et al. Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German multicenter trial group and confirmed polymerase chain reaction analysis. Blood. 2002;99:1536–43.CrossRefPubMed
Metadata
Title
Adult precursor B lymphoblastic leukemia in Shanghai, China: characterization of phenotype, cytogenetics and outcome for 137 consecutive cases
Authors
Liming Bao
Sherilyn A. Gross
John Ryder
Xiaoqin Wang
Meirong Ji
Yan Chen
Yongchen Yang
Saijuan Zhu
Richard D. Irons
Publication date
01-05-2009
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2009
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-009-0283-8

Other articles of this Issue 4/2009

International Journal of Hematology 4/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine